Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Obstet Gynecol ; 85(4): 608-13, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7898842

RESUMEN

OBJECTIVE: To evaluate the safety and efficacy of serial frequent intravaginal prostaglandin (PG) E2 gel applications in shortening the time required to achieve an inducible cervix. METHODS: From May 1, 1993, through April 30, 1994, 101 pregnant women with medical indications for induction of labor and Bishop scores less than 7 were randomized to receive intravaginal 2.5 mg of PGE2 gel every 6 hours or as often as every hour until the Bishop score was at least 7 or intervention was required. RESULTS: The mean total number of PGE2 gel applications was significantly different between the 1- and 6-hour groups, 6.5 and 4.4 PGE2 applications, respectively. The mean time from PGE2 application to delivery was similar, 42 and 45 hours, for the 1- and 6-hour groups, respectively. The intervention rate, occurrence of labor during ripening, and neonatal outcomes were also similar. CONCLUSION: Intravaginal application of 2.5 mg PGE2 gel as frequently as every hour appears to be safe, but it does not decrease the time interval to induction or delivery, nor does it decrease the cesarean rate.


Asunto(s)
Cuello del Útero/efectos de los fármacos , Dinoprostona/administración & dosificación , Trabajo de Parto Inducido/métodos , Contracción Uterina/efectos de los fármacos , Administración Intravaginal , Adolescente , Cuello del Útero/fisiología , Esquema de Medicación , Femenino , Geles , Humanos , Embarazo , Resultado del Embarazo , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...